According to NextBiopharm’s new feature —“R&D Ranking”. This tool groups drugs by their target and mechanism of action, then ranks them based on the highest phase of development they’ve reached globally and the start time of that phase. So here's a interesting finding: Among China's ...
Metaverse, Artificial Intelligence, Data Analytics, Machine Learning, Digitalization: these topics are ranking high on the agenda of the business leaders who understand the competitive advantages that can be seized by moving now into the future of this sector. Infomineo's presentation focuses on som...
Meanwhile, three not-so-lucky contenders fell out of the top 20 just since last summer, when EvaluatePharma published its annual ranking; you can get more info on them by clicking through.Xarelto, Bayer and Johnson & Johnson's ($JNJ) blockbuster anticoagulant, lost ground after its head-to-...
Nov 9, 2024 When it comes to the development of new drugs as of January 2024, Swiss-based company Roche was the leader among the global top pharmaceutical companies. With 218 products in the R&D pipeline, Roche leads the ranking, closely followed by U.S. company Pfizer. Among the global ...
A ranking list is made according to the correct rate and answer time. The event was officially launched on September 27, and ended on October 15. The enterprises had very high enthusiasm in participation, reaching more than 25,000 person- times. There were many participants with a correct ...
Best States Best States is an interactive platform developed by U.S. News for ranking the 50 U.S. states, alongside news analysis and daily reporting. The platform is designed to engage citizens and government leaders in a discussion about what needs improvement across the country....
However, Galliher also forewarned that as CDMO capacity becomes constrained inevitably biotechs advancing targets may now need to look at alternative manufacturing strategies and perhaps use the improved venture capital markets to build their ...
He said Korea’s research efficiency for new drug development was relatively high, ranking 10th among the 20 OECD members. However, the nation’s development efficiency ranked low at 15th because many papers and patents did not lead to good clinical trials and approval results, he noted. ...
But, as 2023 featured major patent expirations, the rise of weight loss drugs and other new dynamics, the year’s ranking of the top 20 drugs by global sales featured its fair share of surprises. Merck’s oncology king Keytruda rose to the top last year, adding yet another feather in ...
“I think we all see the value we can get from a connected digital health ecosystem in the healthcare space,” says Robinet. “But we need an integrated system, and we also need things that are motivating and rewarding people for taking control of their own health data.” He cites the ...